Guobang Pharma Ltd. (605507.SS) — Stock Score Summary

Guobang Pharma Ltd. (605507.SS) has a MoatMap StockRank of 84/100 based on Quality (64/100), Value (63/100), and Momentum (41/100) factor scores. The current signal is STRONG BUY. Guobang Pharma is primarily an API manufacturer; while it operates in healthcare, API production is highly commoditized and faces structural headwinds from Western supply chain localization.

Guobang Pharma Ltd. manufactures active pharmaceutical ingredients (APIs), systematic chemical products, and veterinary drugs, with a focus on anti-infectives and cardiovascular therapies. The company is a global scale leader in several key API categories, including macrolide antibiotics and quinolones, exporting to over 110 countries. Its competitive moat is built on highly integrated, large-scale chemical synthesis platforms and strict compliance with international GMP standards.

Key Financial Metrics

Price$2.35
Market Cap$1.8B
P/E (TTM)16.11
Price/Book1.43
Return on Equity9.0%
Return on Invested Capital10.8%
Debt/Equity11.41
Gross Margin24.6%
Operating Margin13.6%
Revenue Growth5.6%
Dividend Yield2.7%
Free Cash Flow$16M

Guobang Pharma Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Guobang Pharma Ltd.’s (605507.SS) StockRank?
MoatMap’s StockRank for Guobang Pharma Ltd. (605507.SS) is 84/100, with a Strong Buy signal. It is a composite of Quality (64), Value (63), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does Guobang Pharma Ltd. have an economic moat?
Guobang Pharma Ltd. (605507.SS) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guobang Pharma Ltd. a buy, hold, or sell?
MoatMap’s current signal for Guobang Pharma Ltd. (605507.SS) is Strong Buy, based on a StockRank of 84/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guobang Pharma Ltd. in?
Guobang Pharma Ltd. (605507.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks605507.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock